+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 50Years - 75Years
MALE
Healthy Volunteers
ID07422597

Comparison of Upfront MRI Versus Risk Calculator for Men With Suspected Prostate Cancer Using European Risk Stratification Tools

Led by Norwegian University of Science and Technology · Updated on 2026-10-21

1016

Participants Needed

3

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Prostate cancer is the most common non-skin cancer among men, often detected after an elevated prostate-specific antigen PSA blood test. Many men with elevated PSA do not have harmful cancer, leading to potentially unnecessary MRI scans and biopsies. This trial evaluates whether machine learning risk calculators can detect clinically significant prostate cancer as effectively as current MRI-based methods while reducing unnecessary procedures and anxiety. Participants will undergo risk stratification using the European Randomised Study of Screening for Prostate Cancer risk calculators to decide who needs further MRI scans and biopsies. This approach is compared to the current practice of performing MRI for all men with suspicious PSA levels. The study examines if risk stratification can safely reduce the number of MRIs and biopsies needed for diagnosis. Men in the study will be monitored during the initial diagnostic work-up, which lasts up to six weeks, with assessments including detection of clinically significant and insignificant prostate cancer and perilesional biopsy results. Follow-up will occur one year after inclusion to evaluate the number of biopsies and MRIs performed, quality of life related to biopsy decisions, and cost-effectiveness of the risk stratification approach.

CONDITIONS

Brief Title

Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer

Research Team

P

Petter Davik, MD, PhD

J

Joakim S Lund, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here